Acology: One Product, Two Growing Markets

CORONA, CA--(Marketwired - November 18, 2015) - Acology Inc. (OTC PINK: ACOL) has just returned from the National Re-Admission Prevention Collaborative conference held at Good Samaritan Hospital in Los Angeles and reports extremely positive interest and feedback in its signature product, The MedTainer™.

Attended by national and international companies that are part of the growing geriatric, palliative and hospice care industries and companies such as Silverado, Gentiva, Vitas, Medline and Sharp in attendance, the conference reserved part of its focus on new products in which the MedTainer stood above the crowd. Acology executives were given the opportunity to present the MedTainer to more than 250 administrators, clinicians, physicians and senior care providers in attendance. Interest in Acology and its products was very sharp and agreements for clinical applications have been agreed upon.

Having already initiated clinical trials with several large medical organizations, Acology is finding itself in the enviable position of providing its singular, revolutionary product to two very different and burgeoning industries.

Simply taken in its most basic terms, the hospice, palliative and geriatric industry is a multi-billion dollar business that will soon become a multi-trillion dollar business. As Acology continues to make inroads in the industry and more recognition is given to Acology products, the likelihood of substantial sales increases becomes inevitable.

But added to that is the fact that Acology products are already in large demand in the flourishing MMJ and RMJ markets. Both industries are online to show dramatic increases in 2016 as more states legalize and Baby Boomers become one year older. Acology has positioned itself to take advantage of this unique combination of markets and opportunities.

Safe Harbor Statement

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Acology Inc. and D&C Distributors are located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The company's website is www.Acologyinc.com. Please send inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649)